XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2021   20,085,336    
Beginning balance at Dec. 31, 2021 $ 715,339 $ 249,856 $ 444,343 $ 21,140
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 37,672   37,672  
Share-based compensation expense 2,297 $ 2,297    
Common stock issued - Stock grants (in shares)   126,218    
Common stock issued - Stock grants 0 $ 0    
Other comprehensive income (loss) (84,403)     (84,403)
Dividends declared on common stock (13,797)   (13,797)  
Common stock repurchased (in shares)   (1,498,765)    
Common stock repurchased (76,341) $ (27,377) (48,964)  
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2022   18,712,789    
Ending balance at Jun. 30, 2022 580,767 $ 224,776 419,254 (63,263)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2022   18,700,536    
Beginning balance at Mar. 31, 2022 601,231 $ 223,718 408,442 (30,929)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 17,721   17,721  
Share-based compensation expense 1,221 $ 1,221    
Common stock issued - Stock grants (in shares)   21,378    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (32,334)     (32,334)
Dividends declared on common stock (6,633)   (6,633)  
Common stock repurchased (in shares)   (9,125)    
Common stock repurchased (439) $ (163) (276)  
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2022   18,712,789    
Ending balance at Jun. 30, 2022 $ 580,767 $ 224,776 419,254 (63,263)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022 18,730,380 18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 435,085 (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (26,384)   (26,384)  
Share-based compensation expense 1,984 $ 1,984    
Common stock issued - Stock grants (in shares)   59,311    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (1,239)     (1,239)
Dividends declared on common stock (8,569)   (8,569)  
Common stock repurchased (in shares)   (13,094)    
Common stock repurchased $ (316) $ (316) 0  
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2023 18,776,597 18,776,597    
Ending balance at Jun. 30, 2023 $ 527,623 $ 228,260 400,132 (100,769)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2023   18,767,811    
Beginning balance at Mar. 31, 2023 574,994 $ 227,293 433,459 (85,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (31,442)   (31,442)  
Share-based compensation expense 968 $ 968    
Common stock issued - Stock grants (in shares)   8,885    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (15,011)     (15,011)
Dividends declared on common stock (1,885)   (1,885)  
Common stock repurchased (in shares)   (99)    
Common stock repurchased $ (1) $ (1)    
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2023 18,776,597 18,776,597    
Ending balance at Jun. 30, 2023 $ 527,623 $ 228,260 $ 400,132 $ (100,769)